These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 468382)

  • 21. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of tetanus antitoxin. II. Toxin neutralization.
    Peel MM
    J Biol Stand; 1980; 8(3):191-207. PubMed ID: 7410443
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of tetanus in man and animal following injury].
    Radvila P
    Arch Exp Veterinarmed; 1975 Jun; 29(3):469-81. PubMed ID: 1190969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of tetanus antitoxin in human sera. II. Comparison of counter-immunoelectrophoresis and passive haemagglutination with toxin neutralization in mice.
    Winsnes R; Christiansen G
    Acta Pathol Microbiol Scand B; 1979 Jun; 87B(3):197-200. PubMed ID: 474133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of tetanus toxin by human and rabbit immunoglobulin classes and subunits.
    Ourth DD; MacDonald AB
    Immunology; 1977 Dec; 33(6):807-15. PubMed ID: 590997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of the immune response of inoculated and intact animals to the administration of toxigenic and nontoxigenic strains of Clostridium tetani].
    Shvarts SA; Stovbun SF; Bukova VE; Anisimova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):82-6. PubMed ID: 3518309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal tetanus despite protective serum antitoxin concentration.
    Maselle SY; Matre R; Mbise R; Hofstad T
    FEMS Microbiol Immunol; 1991 Jun; 3(3):171-5. PubMed ID: 1878260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
    Simpson LL; Lake P; Kozaki S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera.
    Hendriksen CF; vd Gun JW; Nagel J; Kreeftenberg JG
    J Biol Stand; 1988 Oct; 16(4):287-97. PubMed ID: 3198659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test.
    Souza Matos DC; Marcovistz R; Cabello PH; Georgini RA; Sakauchi D; da Silva LL
    Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):909-13. PubMed ID: 12386721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the immune response to papain digestion products of tetanus toxin.
    Helting TB; Nau HH
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Some experimental data on the seroprophylaxis of tetanus].
    Bistoni F; Mosci L; Vecchiarelli A; Marconi P; Pitzurra M
    Ann Sclavo; 1977; 19(2):285-92. PubMed ID: 603268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P; Sato H; Sato Y; Locht C
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against the light chain of tetanus toxin in human sera.
    Lin CS; Habig WH; Hardegree MC
    Infect Immun; 1985 Jul; 49(1):111-5. PubMed ID: 2409006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neutralization of tetanus toxin in the body].
    Aleksevich IaI
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):15-9. PubMed ID: 6994412
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of local tetanus in rats: neural ascent of tetanus toxin.
    King LE; Fedinec AA
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):391-401. PubMed ID: 4275259
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.
    Norton PM; Wells JM; Brown HW; Macpherson AM; Le Page RW
    Vaccine; 1997; 15(6-7):616-9. PubMed ID: 9178460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro Toxin-Binding Inhibition (ToBI) test.
    Hendriksen CF; van der Gun JW; Kreeftenberg JG
    J Biol Stand; 1989 Apr; 17(2):191-200. PubMed ID: 2715153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local tetanus in cats: neuropharmacokinetics of 125 I-tetanus toxin.
    Wellhöner HH; Hensel B; Seib UC
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(3-4):375-86. PubMed ID: 4268166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.